News
TipRanks on MSN2d
AstraZeneca’s Baxdrostat Study: A Potential Game-Changer for Primary Aldosteronism
AstraZeneca (($AZN)) announced an update on their ongoing clinical study. Study Overview: AstraZeneca is conducting a Phase III clinical trial ...
PURPOSE: Two identical, concurrent, parallel, multicenter, randomized, double-blind, double-dummy trials were conducted to compare the efficacy and safety of zoledronic acid and pamidronate for ...
Lantern Pharma advances pediatric CNS cancer treatment with FDA guidance on LP-184 trial, targeting rare tumors and enhancing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback